These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 1934845)

  • 1. Response of patients with myelofibrosis to megadose methylprednisolone.
    Cohn SL
    Clin Pediatr (Phila); 1991 Oct; 30(10):605. PubMed ID: 1934845
    [No Abstract]   [Full Text] [Related]  

  • 2. Megadose methylprednisolone for the treatment of myelofibrosis.
    Ozsoylu S
    Clin Pediatr (Phila); 1992 Aug; 31(8):511-2. PubMed ID: 1643772
    [No Abstract]   [Full Text] [Related]  

  • 3. Megadose methylprednisolone for myelofibrosis.
    Ozsoylu S
    Acta Haematol; 1993; 89(3):167. PubMed ID: 8362609
    [No Abstract]   [Full Text] [Related]  

  • 4. Megadose methylprednisolone effect on myelofibrosis and granulocyte-macrophage colony-stimulating factor.
    Ozsoylu S
    Acta Haematol; 1994; 91(1):54. PubMed ID: 8171940
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment of myelofibrosis and primary erythermalgia.
    Ozsoylu S
    Am J Hematol; 1993 Jun; 43(2):154-5. PubMed ID: 8342546
    [No Abstract]   [Full Text] [Related]  

  • 6. Myelofibrosis in children.
    Ozsoylu S
    Pediatr Hematol Oncol; 1994; 11(3):339-40, 347. PubMed ID: 8060819
    [No Abstract]   [Full Text] [Related]  

  • 7. High dose intravenous methylprednisolone for idiopathic myelofibrosis.
    Ozsoylu S
    Br J Haematol; 1988 Nov; 70(3):388. PubMed ID: 3207634
    [No Abstract]   [Full Text] [Related]  

  • 8. Intravenous methylprednisolone for myelofibrosis.
    Ozsoylu S
    Acta Haematol; 1989; 82(2):109. PubMed ID: 2508395
    [No Abstract]   [Full Text] [Related]  

  • 9. High-dose intravenous corticosteroid treatment in childhood idiopathic myelofibrosis.
    Ozsoylu S; Ruacan S
    Acta Haematol; 1986; 75(1):49-51. PubMed ID: 3088887
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-dose intravenous methylprednisolone in the treatment of idiopathic myelofibrosis.
    Ozsoylu S
    Eur J Haematol; 1988 Mar; 40(3):280. PubMed ID: 3356244
    [No Abstract]   [Full Text] [Related]  

  • 11. High-dose intravenous methylprednisolone for idiopathic myelofibrosis.
    Ozsoylu S
    Lancet; 1988 Apr; 1(8588):766. PubMed ID: 2895290
    [No Abstract]   [Full Text] [Related]  

  • 12. Combined treatment with thalidomide, corticosteroids, and erythropoietin in patients with idiopathic myelofibrosis.
    Benetatos L; Chaidos A; Alymara V; Vassou A; Bourantas KL
    Eur J Haematol; 2005 Mar; 74(3):273-4. PubMed ID: 15693801
    [No Abstract]   [Full Text] [Related]  

  • 13. High dose i.v. MP for idiopathic myelofibrosis: a further case.
    Ozsoylu S
    Eur J Haematol; 1988 Mar; 40(3):282. PubMed ID: 3356246
    [No Abstract]   [Full Text] [Related]  

  • 14. About primary myelofibrosis.
    Ozsoylu S
    Eur J Haematol; 1988 Nov; 41(5):509. PubMed ID: 3208874
    [No Abstract]   [Full Text] [Related]  

  • 15. The effects of megadose methylprednisolone therapy on the immune system in childhood immune thrombocytopenia.
    Yetgin S; Yenicesu IC; Ersoy F
    Pediatr Hematol Oncol; 2005; 22(5):401-7. PubMed ID: 16020130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical course of children with immune thrombocytopenic purpura treated with intravenous immunoglobulin G or megadose methylprednisolone or observed without therapy.
    Duru F; Fisgin T; Yarali N; Kara A
    Pediatr Hematol Oncol; 2002 Jun; 19(4):219-25. PubMed ID: 12051587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Myelofibrosis in patients with chronic myeloid leukemia treated with interferon-alpha].
    Kumas Sotiris ; Semenova EA; Turkina AG; Zakharova AV; Domracheva EV; Khoroshko ND; Frank GA
    Arkh Patol; 2003; 65(4):9-12. PubMed ID: 14518186
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of cutaneous hemangiomas: a retrospective analysis of 1109 cases and comparison of conventional dose prednisolone with high-dose methylprednisolone therapy.
    Akyüz C; Yariş N; Kutluk MT; Büyükpamukçu M
    Pediatr Hematol Oncol; 2001; 18(1):47-55. PubMed ID: 11205840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The action of methylprednisolone acetate in the local therapy of ganglions].
    La Villa G
    Clin Ter; 1968 Dec; 47(5):455-75. PubMed ID: 5706852
    [No Abstract]   [Full Text] [Related]  

  • 20. Oral megadose methylprednisolone administration in hematologic disorders.
    Ozsoylu S
    Pediatr Hematol Oncol; 1994; 11(5):565, 563-4. PubMed ID: 7826852
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.